An Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers
Completed · Phase 1
Conditions studied: Subcutaneous Adipose Tissue Reduction
In brief
An Evaluation of the PK and Safety of LIPO-102 in Healthy Volunteers.
Key facts
- Study ID
- NCT00918606
- Run by
- Neothetics, Inc
- People needed
- 30
- Starts
- 2009-02-01
- Expected to finish
- 2009-06-01
- Last updated by the study team
- 2015-03-24
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Male and non pregnant female
- 18-55 years old
- Sufficient abdominal fat for injections
- Signed informed consent
You may not qualify if…
- Known hypersensitivity to study drugs
- Treatment with an investigational agent within 30 days before first dose
Where it is running
- Study site — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.